Evidence map›Paper›PMID 26043696›Full record

ArticleBiochemical and biophysical research communications2015

Valosin-containing protein (VCP/p97) is capable of unfolding polyubiquitinated proteins through its ATPase domains.

Changcheng Song, Qing Wang, Changzheng Song, Thomas J Rogers

Abstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. CRL3Molecular cell · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Changcheng SongCenter for Inflammation, Translational and Clinical Lung Research, School of Medicine, Temple University, Philadelphia, PA 19140, USA. Electronic address: songc@temple.edu.
Qing WangGraduate Center for Toxicology, University of Kentucky, Lexington, KY 40536, USA.
Changzheng SongErythrocrine Project of Translational Medicine, Shandong Academy of Medical Sciences, Jinan 250062, China.
Thomas J RogersCenter for Inflammation, Translational and Clinical Lung Research, School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Temple Lung Center · USThe Graduate Center, CUNY · USTemple University · US

Funding

Pilot Projects Core (PPC)P30DA013429 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI Anjali M Rajadhyaksha · 2000 to 2026
$34.6M
Opioid &Chemokine Receptor Interactions Relative to HIVR01DA014230 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI ROGERS, THOMAS J · 2001 to 2016
$5.0M
Role of Valosin-Containing Protein (VCP/p97) in Cadmium-Disturbed ProteostasisR21ES023051 · NIEHS · TEMPLE UNIV OF THE COMMONWEALTH · PI SONG, CHANGCHENG CHARLIE · 2013 to 2014
$426k
NIDA NIH HHS DA-14230NIDA NIH HHS P30 DA013429NIDA NIH HHS R01 DA014230NIEHS NIH HHS 1R21ES023051NIEHS NIH HHS R21 ES023051
6 · The paper itself

Abstract

Valosin-containing protein (VCP or p97) is required for the proteasomal degradation of polyubiquitinated proteins. However, the molecular mechanism for VCP to process the polyubiquitinated proteins remains unclear. Here, we show that VCP can unfold polyubiquitinated proteins. It preferably unfolds the pentaubiquitin-over monoubiquin-conjugated dihydrofolate reductase (Ub5-DHFR or Ub-DHFR) in a dose dependent manner. In addition, the unfolding activity of VCP does not depend on its ATPase activity, on the contrary, ATP and its non-hydrolysable analogs suppress the unfolding of Ub5-DHFR. The structural and functional analysis showed that either D1 or D2 domain of VCP is sufficient to carry out this unfolding activity. The structure of the substrates also affects its unfolding by VCP. VCP is unable to unfold Ub5-DHFR in a tight structure when it binds with methotrexate, a folate analog with high affinity to DHFR. Thus, these results support that VCP is capable of unfolding polyubiquitinated proteins and suggest that VCP may facilitate the proteasomal degradation of polyubiquitinated proteins through its unfolding activity.

Indexed as

Protein UnfoldingUbiquitinationAdenosine TriphosphatasesAdenosine TriphosphateCell Cycle ProteinsChymotrypsinProtein Structure, TertiaryRecombinant ProteinsTetrahydrofolate DehydrogenaseValosin Containing ProteinAdenosine TriphosphatasesAdenosine TriphosphateCell Cycle ProteinsChymotrypsinRecombinant ProteinsTetrahydrofolate DehydrogenaseValosin Containing ProteinATPasePolyubiquitinated proteinStructure and functional analysisUnfoldingValosin-containing protein (VCP or p97)

Identifiers

PMID26043696
PMCPMC4470855
OpenAlexW584377571

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.